April 27, 2023
VIA EDGAR
Joshua Gorsky
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Taysha Gene Therapies, Inc.
Registration Statement on Form S-3 (File No. 333-271144)
Request for Acceleration of Effective Date
Acceleration Request
Requested Date: Monday, May 1, 2023
Requested Time: 4:00 p.m. Eastern Time
Dear Mr. Gorsky:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-271144) (the Registration Statement) to become effective on Monday, May 1, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, Paul Alexander, at (202) 776-2118.
Very truly yours, | ||
TAYSHA GENE THERAPIES, INC. | ||
By: | /s/ Sean P. Nolan | |
Sean P. Nolan | ||
Chief Executive Officer |